tapentadol and Peripheral-Arterial-Disease

tapentadol has been researched along with Peripheral-Arterial-Disease* in 1 studies

Other Studies

1 other study(ies) available for tapentadol and Peripheral-Arterial-Disease

Article	Year
Tapentadol Prolonged Release Reduces the Severe Chronic Ischaemic Pain and Improves the Quality of Life in Patients with Type 2 Diabetes. Journal of diabetes research, 2018, Volume: 2018 This study has been performed in diabetic type 2 patients with pain due to peripheral artery disease (PAD) in order to evaluate the efficacy and tolerability of tapentadol prolonged release (PR). Topics: Aged; Aged, 80 and over; Analgesics; Chronic Pain; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Humans; Male; Middle Aged; Pain; Pain Measurement; Peripheral Arterial Disease; Phenols; Quality of Life; Tapentadol; Treatment Outcome	2018

Article

Year

Tapentadol Prolonged Release Reduces the Severe Chronic Ischaemic Pain and Improves the Quality of Life in Patients with Type 2 Diabetes.

Journal of diabetes research, 2018, Volume: 2018

This study has been performed in diabetic type 2 patients with pain due to peripheral artery disease (PAD) in order to evaluate the efficacy and tolerability of tapentadol prolonged release (PR).

Topics: Aged; Aged, 80 and over; Analgesics; Chronic Pain; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Humans; Male; Middle Aged; Pain; Pain Measurement; Peripheral Arterial Disease; Phenols; Quality of Life; Tapentadol; Treatment Outcome

2018